As we enter the fall of 2012, we're well into the "roll-out" phase of the new CLSI EP23 guideline. There have been articles, "advertorials", webinars, workshops and more - all about the new Risk Analysis Approach. But what's interesting is that while Risk Analysis is somewhat "new" to US healthcare, it's been done for years in other countries. US laboratories should take serious note of recent articles on the effectiveness of these Risk Analysis techniques in healthcare.
Please Login (at right) or Register to view article